Decreased phototherapy effectiveness on lower body by Piccinin, Meghan A et al.
UC Davis
Dermatology Online Journal
Title
Decreased phototherapy effectiveness on lower body
Permalink
https://escholarship.org/uc/item/7pg2g8zf
Journal
Dermatology Online Journal, 25(6)
Authors
Piccinin, Meghan A
Cline, Abigail
Feldman, Steven R
Publication Date
2019
License
CC BY-NC-ND 4.0
eScholarship.org Powered by the California Digital Library
University of California
Volume 25 Number 6| June 2019| 
25(6):4 
 
 
- 1 - 
Dermatology Online Journal  ||  Commentary
Decreased phototherapy effectiveness on lower body 
 
Meghan A Piccinin1, Abigail Cline1, Steven R Feldman1,2 
Affiliations: 1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, 
North Carolina, USA, 2Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA 
Corresponding Author: Meghan Piccinin, Department of Dermatology, Wake Forest School of Medicine, Medical Center Boulevard, 
Winston-Salem, NC 27157-1071, Tel: 336-716-7740, Fax: 336-716-7732, Email: piccininma@upmc.edu 
 
 
 
 
 
Keywords: phototherapy 
 
Introduction 
Phototherapy is a commonly-employed treatment 
modality for a number of cutaneous disorders, 
including atopic dermatitis, vitiligo, and psoriasis. 
Although phototherapy is an effective treatment for 
many dermatological conditions on the face, trunk, 
and proximal extremities, a common issue plaguing 
whole-body phototherapy is its diminished efficacy 
on the legs [1, 2]. In this commentary, we elaborate 
on the factors underlying this phenomenon, as well 
as potential solutions to improve treatment success. 
Ultraviolet (UV) B phototherapy with a wavelength of 
280-315 nanometers is largely restricted to the 
epidermis. Thus, the physiologic response to 
phototherapy is dictated by the effective dose of 
irradiance received at the skin surface [3]. The 
irradiance, or photonic emission, from a 
phototherapy tube may be modelled as a continuum 
of point sources arranged into a linear series [3]. Each 
individual point source emits a diffuse spherical array 
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Figure 1. Relative irradiance of body regions during 
phototherapy treatment. A) The Lambert Cosine Law 
demonstrates that the irradiance provided by an angled photon 
is proportional to its angle from the normal. B) The total 
irradiance received by a point is equal to the summation of the 
irradiance provided by each individual photon. C)  A detector 
placed at the midpoint of the cabin receives irradiance from 
above and below. D) If only light sources above the level of the 
detector are considered, the detector will receive 50% of the total 
irradiance, equivalent to the irradiance at the bottom of the 
chamber. E) The midbody receives irradiance from above and 
below. F) The legs receive high-energy photons from light sources 
directly opposed to the region, as well as lower-energy photons 
from superior light sources. The legs do not receive irradiance 
from below. G) Having the patient stand on a stool within the 
phototherapy cabin allows for increased irradiation of the lower 
extremities by inferior sources, increasing the total radiant 
dosage received by the legs. 
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of photons that strike the patient’s body at a variety 
of angles. As the angle of the photon increases 
relative to the normal plane, the radiance provided 
by that specific photon diminishes in proportion to 
the cosine of the angle of incidence, in accordance 
with the Lambert Cosine Law (Figure 1A), [4]. 
Based on this law, photons emitted at a lesser angle 
will contribute more radiant energy to total 
irradiance than those emitted from sources high 
above or far below the target body region and the 
total energy received at any point on the body will 
equal the sum of energy contributed from all point 
sources (Figure 1B), [3, 5]. A detector placed in the 
middle of the phototherapy chamber will receive 
irradiance from above and below (Figure 1C). 
Alternatively, a detector placed at the base of the 
cabin will receive irradiance only from above, 
resulting in a radiation dose half of that received in 
the middle of the booth (Figure 1D). 
The middle area of the body receives high-energy 
photons from the regions of the tube located in 
direct apposition, as well as lower-energy photons 
from superior and inferior regions of the tube 
(Figure 1E). Alternatively, the legs receive high-
energy photons from the directly apposed regions of 
the tube and lower-energy photons from superior 
sections of the cabin but fail to receive photonic 
energy from light sources located below (Figure 1F). 
Thus, the distal lower extremities receive a lower 
effective dose of irradiation relative to the central 
body regions, contributing to their apparent 
resistance to conventional phototherapy. 
Discussion 
To overcome this therapeutic challenge, a stepstool 
within the phototherapy cabin can be used move the 
legs up and away from the bottom of the 
phototherapy unit, increasing the irradiance to the 
legs by inferiorly-located light sources (Figure 1G). 
Alternatively, patients may undergo additional or 
prolonged leg-specific phototherapy sessions by 
dressing the patient in a UV-protective gown or robe 
to restrict irradiation to the legs. Enacting 
modifications that allow for greater dosing of the 
legs and ensuring more equivalent full-body dosing 
may lead to improved clinical outcomes for patients 
with ‘stubborn’ cutaneous disease of the lower 
extremities. 
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